Debt-to-equity of Vaxxinity, Inc. from 30 Jun 2022 to 31 Dec 2023
Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Vaxxinity, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2022 to 31 Dec 2023.
Vaxxinity, Inc. Debt-to-equity for the quarter ending 31 Dec 2023 was 119%, a 159% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)
Vaxxinity, Inc. Quarterly Debt-to-equity (%)
Period
Value
YoY Chg
Change %
Date
Q4 2023
119%
+73%
+159%
31 Dec 2023
Q3 2023
92%
+55%
+148%
30 Sep 2023
Q2 2023
73%
-19%
-21%
30 Jun 2023
Q1 2023
58%
31 Mar 2023
Q4 2022
46%
31 Dec 2022
Q3 2022
37%
30 Sep 2022
Q2 2022
92%
30 Jun 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.